Clinical Trial

Single Shot Exparel vs Catheters in Lower Extremity Trauma

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will compare the use of single-shot Exparel, a long-acting local anesthestic, with the use of catheters that deliver a continuous flow of the short-acting local anesthetic ropivacaine. The comparison will be done in patients who receive preoperative adductor and sciatic nerve blocks prior to orthopedic surgery for traumatic lower extremity injury. The patients' pain will then be monitored for up to 72 hours after injection, measuring every 12 hours after injection until the 72-hour mark. Opioid consumption (measured in morphine milligram equivalents) will also be tracked over this time period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-23.
Trial Details
NCT Number NCT07221019
Lead Sponsor George Washington University
Conditions Fracture Dislocation of Ankle Joint, Fracture Leg, Fracture Femur, Fracture Lower Leg, Fracture
Enrollment 90 participants
Start Date 2025-09-12
Primary Completion 2028-08-11 (estimated)
Study Completion 2029-08-11 (estimated)
Updated on ClinicalTrials.gov 2025-10-28